Overview and evaluation of a nationwide hospital-based surveillance system for Influenza and COVID-19 in Switzerland (CH-SUR): 2018-2023
Jonathan Sobel(University Hospital of Geneva), Domenica Flury, Anne Iten(University Hospital of Geneva), Olivia Keiser(University of Geneva), Peter W. Schreiber(University Hospital of Zurich), Rami Sommerstein(University of Bern), Davide Giovanni Bosetti(Institute of Oncology Research), Didier Pittet(Hôpital Beau-Séjour), Ulrich Heininger(University Children’s Hospital Basel), Stephan Harbarth(University Hospital of Geneva), Anita Niederer-Loher(Ostschweizer Kinderspital), Camille B. Valera(University of Geneva), Rebecca Grant(University Hospital of Geneva), Marie-Céline Zanella(University of Geneva), Petra Zimmermann(University of Fribourg), Khaled Mostaguir(SIB Swiss Institute of Bioinformatics), Philipp Jent(University of Bern), Maria Süveges(University of Geneva), Laura Urbini(University of Geneva), Sara Botero Mesa(University of Geneva), Ursina Roder(Federal Office of Public Health)
Cited by 0
Related Papers
ExPASy: SIB bioinformatics resource portal
|Nucleic Acids Research|2012|2.4k
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
|Archives of Disease in Childhood|2020|534